Practical implication
Sponsors and investigators must develop an implementation plan for the ISO 14155:2026 standard and maintain records for review during TGA inspections, ensuring alignment with updated safety monitoring obligations.
The Therapeutic Goods Administration (TGA) has updated its Good Clinical Practice (GCP) Inspection Program to recognize ISO 14155:2026 as the current standard for clinical investigations of medical devices. A 12-month transition period is established, beginning March 31, 2026, requiring sites to maintain implementation plans and records for TGA inspections. This change mandates that sponsors and investigators revise their safety reporting and vigilance procedures to align with the new standard.
What changed: The TGA's GCP Inspection Program now recognizes ISO 14155:2026 with a 12-month transition period, requiring implementation plans and revised safety reporting practices for compliance.
Why it matters: This update ensures that safety reporting and vigilance methodologies match the latest international standards, enhancing participant safety and data integrity in clinical trials.
Practical implication: Sponsors and investigators must develop an implementation plan for the ISO 14155:2026 standard and maintain records for review during TGA inspections, ensuring alignment with updated safety monitoring obligations.
View original source
Published from the Firecrawl policy change extraction pipeline.
